Advanced Research at the Urology Institute
University Hospitals Urology Institute is dedicated to helping clinicians and physician scientists realize their visions by providing assistance at every level, from coordinating funding to providing state-of-the-art labs.
Our goal is to move potential therapies from bench to bedside as quickly as possible. Each year, our department consistently ranks in the top 25 urology departments for most research funding by the National Institutes of Health (NIH) and our researchers publish more than 150+ scientific peer-reviewed papers annually.
The Parallel Path™
The Parallel Path™ is a newly developed process that provides the infrastructure for a comprehensive research core that will enable our physicians to be productive both clinically and academically.
NIH RO1 Grant
Lee Ponsky, MD is the co-principal investigator on an NIH R01 grant to develop a combined quantitative MRI and computerized decision support exam for more accurate detection and grading of prostate cancer both in the peripheral and transitional zones.
Case-Coulter Translational Research Partnership
Agata Exner, PhD, Jim Basilion, PhD, & Lee Ponsky, MD; “Drug-Free Targeted Prostate Cancer Treatment with TNT–Targeted Nanobubble Therapy”—December 2020
Breakthrough Research in Synthetic Mesh
Adonis Hijaz, MD, along with a team of physicians and engineers from UH and Case Western Reserve University have developed a novel woven collagen mesh material for potential use in mid-urethral sling (MUS) surgeries.
Harnessing clinical data to identify new prostate cancer therapeutics
Jonathan E. Shoag, MD is working to identify drugs that have activity against the normal prostate and can be used to understand and treat prostate cancer.
UH Research & Education Institute Pilot Award
Laura Bukavina, MD, MPH principal investigator; “Impact of Mental Health Treatment on Bladder Cancer Mortality in US Veterans” – October 2020